While PrEP tablets are already prescribed around the world to prevent people from contracting HIV, experts in the US hope a newly approved jab could improve rates of protection.

Whereas the new HIV prevention drug, Lenacapavir, is a positive step towards HIV prevention, its cost is prohibitive. The ...

This article explores the complex interplay between drug addiction and HIV, highlighting how integrated harm reduction ...

Indian firms have secured rights to produce Lenacapavir, a twice-yearly HIV injection, making treatment easier and affordable ...

The FDA's approval of lenacapavir, a highly effective HIV prevention drug, sparks debate in India due to its high cost of ₹24 ...

HIV targets the white blood cells and weakens the immune system. This would make the person prone to diseases like ...

The US FDA has approved lenacapavir, the first twice-yearly injection for HIV prevention, which provides near-complete ...

Every morning, to avoid getting sick, Jessica Baudean must take a long trip across the Mississippi. Baudean, who is disabled, ...